Summary At the 2015 World Health Assembly, UN member states adopted a resolution that
committed to the development of national action plans (NAPs) for antimicrobial resistance …

Background Health-care workers constitute a high-risk population for acquisition of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Capacity for acute …

Background Accurate antibody tests are essential to monitor the SARS-CoV-2 pandemic.
Lateral flow immunoassays (LFIAs) can deliver testing at scale. However, reported …

Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management - The
Lancet Skip to Main Content Advertisement The Lancet Journal Submit Article Log in Register …

Objective To evaluate the performance of new lateral flow immunoassays (LFIAs) suitable
for use in a national coronavirus disease 2019 (covid-19) seroprevalence programme (real …

Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies -
Journal of Infection Skip to Main Content Advertisement Journal of Infection Submit Log in …

Background Older adults, particularly in long-term care facilities (LTCF), remain at
considerable risk from SARS-CoV-2. Data on the protective effect and mechanisms of hybrid …

Objective To assess how national antimicrobial susceptibility data used to inform national
action plans vary across surveillance platforms. Methods We identified available open …

Human conflict, such as the ongoing conflict in Ukraine, is an important driver of
antimicrobial resistance. Here, we describe the challenges when addressing this problem …

We commend the recent comments from Undurraga and colleagues, which continue to
highlight challenges in antimicrobial resistance (AMR) in the Americas. 1 While the cost …